SCHEMBL4367985

SCHEMBL4367985

CN(C(N)=O)C(=O)c1ncc(-c2cccc(Cl)c2)cc1O.CN(C)C(=O)CNC(=O)c1ncc(-c2cccc(Cl)c2)cc1O

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 18/20 0.64
VEGFA P15692 7/20 0.64
FLT1 P17948 7/20 0.64
EGLN3 Q9H6Z9 7/20 0.64
TET3 O43151 1/20 0.64
BBOX1 O75936 1/20 0.64
ASPH Q12797 1/20 0.64
TET2 Q6N021 1/20 0.64
KDM8 Q8N371 1/20 0.64
OGFOD1 Q8N543 1/20 0.64
TET1 Q8NFU7 1/20 0.64
HIF1AN Q9NWT6 1/20 0.64
GRIN2B Q13224 2/20 0.46
GRIN1 Q05586 1/20 0.46
FTO Q9C0B1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30239592 0.91 EGLN1 (0.76) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL1921047 0.91 EGLN1 (0.76) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL4367990 0.91 EGLN1 (0.69) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL30239851 0.82 EGLN1 (0.80) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL1921390 0.82 EGLN1 (0.80) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL3485005 0.80 EGLN1 (0.75) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL15164149 0.80 EGLN1 (0.80) EGLN1VEGFAFLT1EGLN3TET3
Vadadustat SCHEMBL29405970 0.79 EGLN1 (1.00) EGLN1VEGFAFLT1EGLN3TET3
Vadadustat SCHEMBL1920738 0.79 EGLN1 (1.00) EGLN1VEGFAFLT1EGLN3TET3
Vadadustat SCHEMBL29357486 0.79 EGLN1 (1.00) EGLN1VEGFAFLT1EGLN3TET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044005-B8 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE WARNER CHILCOTT CO LLC (PR) 2012-12-05 EP claimed
EP-2044005-A2 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE The Procter and Gamble Company (US) 2009-04-08 EP claimed
WO-2008002576-A2 PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY (US) 2008-01-03 WO claimed